Brevibacillin 2v, a novel antimicrobial lipopeptide with an exceptionally low hemolytic activity

HIGHLIGHTS

  • who: Oscar P. Kuipers from the Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, of Agricultural Sciences, China have published the paper: Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity, in the Journal: (JOURNAL)
  • what: The experiments were conducted in triplicate, and data are presented as the mean value of triplicate experiments. In the present study, brevibacillins showed a synergistic activity with marketed antibiotics against Gram-negative pathogens.
  • how: To expand the antimicrobial potential of brevibacillins the authors investigated the synergistic activity of brevibacillins . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?